Efficacy and Cost-Effectiveness Analyses of Entecavir versus Tenofovir Amibufenamide in Patients with Chronic Hepatitis B
Drug Design, Development and Therapy · 2026
DOI: 10.2147/dddt.s553277 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Drug Design, Development and Therapy, 2026. Verfasst von Yuhan Zeng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, Antiviral Agents, Cost-Benefit Analysis, Cost-Effectiveness Analysis. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China.
- School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China.
- Zhejiang Key Laboratory of Intelligent Cancer Biomarker Discovery and Translation, First Affiliated Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China.
- Cheeloo College of Medicine, Shandong University, Jinan, Shandong, People's Republic of China.
- Clinical Research Office, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China.
- Clinical Trial Institution Office, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China.
ORCID-Profile: Ziye Zhou
Zitieren
APA
Zeng, Y., Jiang, D., Guo, L., Chen, Y., Weng, J., Liu, X., Qin, S., Kong, M., Zhou, Z., & Zhang, X. (2026). Efficacy and Cost-Effectiveness Analyses of Entecavir versus Tenofovir Amibufenamide in Patients with Chronic Hepatitis B. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s553277
Vancouver
Zeng Y, Jiang D, Guo L, Chen Y, Weng J, Liu X, et al. Efficacy and Cost-Effectiveness Analyses of Entecavir versus Tenofovir Amibufenamide in Patients with Chronic Hepatitis B. Drug Design, Development and Therapy. 2026. doi:10.2147/dddt.s553277
BibTeX
@article{Zeng2026,
author = {Zeng, Yuhan and Jiang, Danna and Guo, Lei and Chen, Yizhang and Weng, Jialu and Liu, Xiaohan and Qin, Sunting and Kong, Mengyu and Zhou, Ziye and Zhang, Xiuhua},
title = {Efficacy and Cost-Effectiveness Analyses of Entecavir versus Tenofovir Amibufenamide in Patients with Chronic Hepatitis B},
journal = {Drug Design, Development and Therapy},
year = {2026},
doi = {10.2147/dddt.s553277}
}
EUVIMED